Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.
1 report, 1 independent
Updated Tue 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jefferies Financial Group
American financial services company
-
Citigroup
American investment bank and financial services corporation
-
Leerink partners
U.S. investment bank
Related events
- Citigroup and Jefferies Financial Group raised their price targets and issued buy ratings for Beauty.
- Jefferies Financial Group reaffirmed a Buy rating on London Stock Exchange Group.
- Jefferies reiterated a hold rating while Citigroup increased its target price and gave a neutral rating for QuidelOrtho Corporation.
- Jefferies cut its rating and price objective while Citigroup reiterated an outperform rating for LXP Industrial Trust.
- Privia Health Group, Inc. shares are listed on the Nasdaq exchange, and Citigroup reissued a buy rating on the stock.